SJOGRENS SYNDROME
Clinical trials for SJOGRENS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new SJOGRENS SYNDROME trials appear
Sign up with your email to follow new studies for SJOGRENS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sjögren's drug ianalumab tested for long-term safety in 612 patients
Disease control OngoingThis study looks at the long-term safety of the drug ianalumab in people with Sjögren's syndrome, an autoimmune disease that causes dry eyes and mouth. Participants must have completed a previous year-long study of ianalumab. The main goal is to track side effects over time, with…
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
New drug aims to tame Sjogren's symptoms in major trial
Disease control OngoingThis study tests whether nipocalimab can safely reduce disease activity in adults with moderate to severe Sjogren's disease, an autoimmune condition causing dry eyes, dry mouth, and other symptoms. About 655 participants receive either the drug or a placebo for 48 weeks. The main…
Matched conditions: SJOGRENS SYNDROME
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated May 15, 2026 11:55 UTC